Multiple studies have found aberrant survivin expression in rheumatoid arthritis (RA) (50), inflammatory bowel disease (IBD) (51), psoriasis (52), systemic Lupus erythematosus (SLE) (53), and multiple sclerosis (MS) (54). Here, BIRC5 is linked to myeloid sarcoma.